Sidley Austin LLP has a notable corporate offering, with particular strength in public M&A across the technology and life sciences sectors. The practice is led by Constance Choy, who provides strategic advice on a broad range of corporate finance matters. Christopher Cheng has extensive experience advising listed companies on commercial transactions and related regulatory issues, including compliance with the Hong Kong Listing Rules, the Codes on Takeovers and Mergers and Share Buy-backs.
Legal 500 Editorial commentary

Accolades

Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®

Testimonials

Collated independently by Legal 500 research team.

  • This practice stands out for its clear, practical guidance and strong communication throughout the matter. Clients want to know what to expect, how the process will unfold, and that their lawyer is actively working toward the best outcome—this team excels at explaining options in plain language, responding promptly, and providing thoughtful strategy rather than generic advice. Compared to other firms, the difference is the personal attention and consistency: you’re kept informed at key stages, timelines are managed well, and the firm focuses on results while treating the client with professionalism and respect.

Key clients

  • MicroPort Cardiac Rhythm Management Limited
  • I-Mab
  • Kroll
  • ABC Impact, backed by Temasek
  • Sino Biopharmaceutical Limited
  • Vivo Capital
  • Novo Holdings
  • Sasken Technologies Limited
Practice head

Constance Choy

Other key lawyers

Christopher Cheng